Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLu, K.en
dc.contributor.authorAsyifah, M. R.en
dc.contributor.authorShao, F.en
dc.contributor.authorZhang, D.en
dc.identifier.citationLu, K., Asyifah, M., Shao, F., & Zhang, D. (2014). Development of HIV-1 Fusion Inhibitors Targeting gp41. Current Medicinal Chemistry, 21(17), 1976-1996.en
dc.description.abstractThe HIV-1 envelope protein glycoprotein 41 (gp41) is crucial in the HIV-1 infection process, therefore gp41 has emerged as an attractive target for drug design against AIDS. During the past few decades, tremendous efforts have been made on developing inhibitors that can prevent the HIV-1 entry process via suppressing functional gp41. In this review, the development of HIV-1 fusion inhibitors targeting gp41 including peptide inhibitors, small molecule inhibitors, vaccines and neutralized antibodies will be discussed.en
dc.relation.ispartofseriesCurrent medicinal chemistryen
dc.rights© 2014 Bentham Science Publishers.en
dc.subjectDRNTU::Science::Medicine::Biomedical engineeringen
dc.titleDevelopment of HIV-1 fusion inhibitors targeting gp41en
dc.typeJournal Articleen
dc.contributor.schoolSchool of Physical and Mathematical Sciencesen
item.fulltextNo Fulltext-
Appears in Collections:SPMS Journal Articles

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.